Answer
Yes, Lumigan 0.1 mg/ml (bimatoprost) is contraindicated in patients whose suspected previous adverse reaction to benzalkonium chloride led to treatment discontinuation.
Sources for this answer
- Lumigan 0.1mg/mlAbbVie Ltd · emc · SmPC §4.3 Contraindications · Version 12Document updated
Sources checked